Upgrade to SI Premium - Free Trial

Aquestive Therapeutics Inc. (AQST)

4.71 +0.28 (6.32%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/4/26)

Latest Headlines

Form 4 Aquestive Therapeutics, For: Jun 15 Filed by: Barber Daniel June 16, 2026 4:09 PM - SEC Filing Form 144 Aquestive Therapeutics, Filed by: Barber Daniel June 15, 2026 4:39 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Jun 10 Filed by: MORRIS TIMOTHY E June 12, 2026 11:43 AM - SEC Filing Form 4 Aquestive Therapeutics, For: Jun 10 Filed by: Krop Julie June 12, 2026 11:43 AM - SEC Filing Form 4 Aquestive Therapeutics, For: Jun 10 Filed by: Jenkins Abigail L. June 12, 2026 11:43 AM - SEC Filing Form 4 Aquestive Therapeutics, For: Jun 10 Filed by: Cochran John June 12, 2026 11:43 AM - SEC Filing Form 4 Aquestive Therapeutics, For: Jun 10 Filed by: BROWN GREGORY B June 12, 2026 11:42 AM - SEC Filing Form 4 Aquestive Therapeutics, For: Jun 10 Filed by: Taglietti Marco June 12, 2026 11:42 AM - SEC Filing Form 8-K Aquestive Therapeutics, For: Jun 10 June 10, 2026 4:02 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Jun 08 Filed by: Korczynski Sherry June 9, 2026 2:48 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 18 Filed by: Zalewski Thomas A. May 19, 2026 12:02 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 15 Filed by: Barber Daniel May 18, 2026 2:03 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 15 Filed by: Cioffi Melina May 18, 2026 12:37 PM - SEC Filing Form 144 Aquestive Therapeutics, Filed by: Barber Daniel May 15, 2026 4:38 PM - SEC Filing Aquestive Therapeutics (AQST) Reiterated at Market Outperform by Citizens May 15, 2026 4:50 AM - StreetInsider Aquestive Therapeutics Inc. (AQST) Tops Q1 EPS by 6c May 13, 2026 4:13 PM - StreetInsider Form 10-Q Aquestive Therapeutics, For: Mar 31 May 13, 2026 4:09 PM - SEC Filing Form 8-K Aquestive Therapeutics, For: May 12 May 13, 2026 4:05 PM - SEC Filing Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update May 13, 2026 4:01 PM - StreetInsider Aquestive Therapeutics secures $150 million debt facility with Oaktree May 12, 2026 9:31 AM - StreetInsider Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree May 12, 2026 9:31 AM - Globe NewsWire Form 4 Aquestive Therapeutics, For: May 07 Filed by: BRAENDER LORI J May 11, 2026 4:36 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: Boyd Peter E. May 7, 2026 5:34 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: Barber Daniel May 7, 2026 5:34 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: TOTH A ERNEST JR May 7, 2026 5:34 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: Jung Cassie May 7, 2026 5:32 PM - SEC Filing Form 4 Aquestive Therapeutics, For: May 05 Filed by: BRAENDER LORI J May 7, 2026 5:32 PM - SEC Filing Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET May 6, 2026 7:00 AM - Globe NewsWire Form ARS Aquestive Therapeutics, For: Dec 31 April 24, 2026 5:11 PM - SEC Filing Form DEFA14A Aquestive Therapeutics, April 24, 2026 5:06 PM - SEC Filing Form DEF 14A Aquestive Therapeutics, For: Jun 10 April 24, 2026 5:01 PM - SEC Filing Oppenheimer Assumes Aquestive Therapeutics (AQST) at Outperform April 24, 2026 6:14 AM - StreetInsider Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Barber Daniel April 13, 2026 3:55 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Boyd Peter E. April 13, 2026 3:54 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Jung Cassie April 13, 2026 3:53 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: TOTH A ERNEST JR April 13, 2026 3:53 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: Korczynski Sherry April 13, 2026 3:52 PM - SEC Filing Form 4 Aquestive Therapeutics, For: Mar 07 Filed by: BRAENDER LORI J April 13, 2026 3:52 PM - SEC Filing Form 3 Aquestive Therapeutics, For: Apr 02 Filed by: Zalewski Thomas A. April 10, 2026 9:56 AM - SEC Filing Form 8-K Aquestive Therapeutics, For: Mar 30 March 30, 2026 7:45 AM - SEC Filing Aquestive completes FDA meeting on Anaphylm drug application March 30, 2026 7:00 AM - StreetInsider Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film March 30, 2026 7:00 AM - StreetInsider Full Article List